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ABSTRACT
Purine nucleosides on position 9 of eukaryal and
archaeal tRNAs are frequently modified in vivo by
the post-transcriptional addition of a methyl group
on their N1 atom. The methyltransferase Trm10 is
responsible for this modification in both these do-
mains of life. While certain Trm10 orthologues specif-
ically methylate either guanosine or adenosine at po-
sition 9 of tRNA, others have a dual specificity. Until
now structural information about this enzyme family
was only available for the catalytic SPOUT domain of
Trm10 proteins that show specificity toward guano-
sine. Here, we present the first crystal structure of
a full length Trm10 orthologue specific for adeno-
sine, revealing next to the catalytic SPOUT domain
also N- and C-terminal domains. This structure hence
provides crucial insights in the tRNA binding mech-
anism of this unique monomeric family of SPOUT
methyltransferases. Moreover, structural compari-
son of this adenosine-specific Trm10 orthologue with
guanosine-specific Trm10 orthologues suggests that
the N1 methylation of adenosine relies on additional
catalytic residues.
INTRODUCTION
Transfer RNA (tRNA) plays a central role in one of the
most crucial processes in living organisms: the translation of
the genetic code into proteins. Control of the structural in-
tegrity and decoding potential of tRNA molecules is there-
fore of utmost importance. This process is influenced in
all domains of life by the presence of post-transcriptional
modifications on tRNA. On average 15% of the nucleotides
of tRNA are modified and over a 100 chemically distinct
tRNA modifications are known to occur in vivo (1). These
modifications aid in the correct functioning of tRNA, and,
depending on the nature and position of these modifica-
tions, they can influence the structure, stability, dynamics
or decoding capacity/efficiency of the tRNA molecule (2).
Among the variety of post-transcriptional modifications
found in tRNA, the addition of a methyl group is one of
the most common. RNA methylation reactions are catal-
ysed by a wide range of structurally distinct methyltrans-
ferases, which can add a methyl group on virtually ev-
ery atom of the base or on the 2′-O-ribose atom (3–6).
In particular, N1-methylated purine nucleosides are fre-
quently found in tRNA and these modifications can be es-
sential for the correct functioning of tRNA (1). For ex-
ample, the N1-methylation of guanosine on position 37 of
tRNA serves a dual role: it prevents frame shifts during
translation (7) and it helps tRNAAsp in avoiding its mis-
charging with arginine by arginyl-tRNA synthetases (8).
In addition, N1-methylated purines can also be essential
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for the proper tRNA structure formation as is seen for the
human mitochondrial tRNALys, which is unable to fold
to its characteristic cloverleaf conformation when it lacks
the m1A9 modification (9). This latter modification reac-
tion at position 9 of tRNA is catalysed in Eukarya and
Archaea by the methyltransferase Trm10 (10,11). Recently
Trm10 has specifically attracted attention due to the dis-
covery that mutations in one of the human cytosolic Trm10
paralogues (TRMT10A) are associated with pathologies in-
volving intellectual disabilities and abnormalities in the glu-
cose homeostasis (12,13).
Among the Trm10 proteins, the representative from Sac-
charomyces cerevisiae has been characterized most thor-
oughly both structurally and biochemically. This enzyme
belongs to the SpoU-TrmD (SPOUT) family of S-adenosyl-
methionine (SAM) dependent methyltransferases (10,14).
The SPOUT family proteins are characterised by a Ross-
manoidal / fold with a C-terminal topological knot,
which forms a binding pocket for the methyl donor SAM
(15,16). Apart from the SPOUT domain, Trm10 proteins
contain additional N- and C-terminal domains, for which
the exact function has not yet been unequivocally deter-
mined. Surprisingly, the yeast Trm10 proteins were found to
be monomeric in solution (14). This makes Trm10 unique
within the SPOUT family, where all other known members
function as dimers (16). In such ‘classical’ SPOUT dimers
the dimeric nature of the protein is believed to aid in tRNA
binding, which was also experimentally confirmed for the
E. coli TrmL protein where a mutant that forces TrmL in
a monomeric form was unable to bind its substrate tRNA
(17). Therefore, themonomeric nature of yeast Trm10 raises
questions on the mode of tRNA binding by this protein.
In humans, three paralogues of Trm10 are present: the
cytosolic TRMT10A and TRMT10B proteins and the mi-
tochondrial TRMT10C. Remarkably, the TRMT10C pro-
tein was found to serve as a subunit for the mitochondrial
RNAse P (mtRNase P) complex, which is the endonucle-
ase responsible for the removal of the tRNA 5′ extension
during tRNA maturation (18). In contrast to cytoplasmic
RNase P,which is a ribonucleoprotein,mtRNase P contains
only proteins. Human mtRNase P is a complex of the three
proteins: PRORP (proteinaceous RNase P), SDR5C1 and
TRMT10C. In this complex, the presence of TRMT10C is
required for the endonuclease activity of mtRNase P, al-
though this requirement is independent of the methyltrans-
ferase activity (19). For its methyltransferase activity, mito-
chondrial TRMT10C in turn requires the presence of the
SDR5C1 protein (19). This contrasts with the S. cerevisiae
and human cytosolic Trm10 homologues that are able to in-
dependently catalyse the N1-methylation of purines in po-
sition 9 of tRNA (19).
The Trm10 orthologues differ with respect to their speci-
ficity towards the purine base at position 9 of the tRNA
substrate. While the S. cerevisiae Trm10 homologue and
the human cytosolic TRMT10A and TRMT10B specifi-
cally N1-methylate guanosine in position 9 of tRNA, the
mitochondrial TRMT10C protein is able to N1-methylate
both guanosine and adenosine (10,19). Such a dual sub-
strate specificity has also been found in the archaeal Trm10
homologue ofThermococcus kodakarensis (TkTrm10), while
the Trm10 homologue from the archaeon Sulfolobus aci-
docaldarius (SaTrm10) is specific for adenosine nucleotides
only (11). Thus far the molecular basis of this difference in
substrate specificity has remained unknown and it is diffi-
cult to imagine how certain enzymes can catalyse themethy-
lation of both adenosine and guanosine considering the dif-
ferent protonation states of their N1 atoms (Supplementary
Figure S1).
Currently, structural information is available for three
Trm10 proteins. Crystal structures of the isolated SPOUT
domains of the G9-specific Trm10 proteins of S. cerevisiae
(ScTrm10) and Schizosaccharomyces pombe (SpTrm10) have
recently been published (14). Moreover, a structure of the
SPOUT domain of the G9-specific human cytosolic Trm10
orthologue TRMT10A, has been deposited in the protein
database (PDB: 4fmw). In this paper we present the first
crystal structure of a full length Trm10 protein (from the ar-
chaeon Sulfolobus acidocaldarius), which shows besides the
SPOUT domain also the molecular structure of the N- and
C-terminal domain. This is the first experimentally deter-
mined structure for an adenosine-specific Trm10 protein.
We also present a model for substrate tRNA binding by
SaTrm10 and we discuss the implications for the methyl-
transfer reaction.
MATERIALS AND METHODS
Expression and purification of SaTrm10 constructs
The SaTrm10 open reading frame (ORF) was amplified by
polymerase chain reaction from genomic DNA and sub-
sequently cloned in a pET28b vector between the restric-
tion sites NdeI and XhoI as described in Kempenaers et al.,
2010 (11). Expression of recombinant protein starting from
this vector results in a protein with an N-terminal histidine-
tag. The SaTrm10 1–249 construct and point mutants of
SaTrm10 were created using the QuickChange site-directed
mutagenesis kit (Stratagene). Alternatively, the SaTrm10
ORF (including the stopcodon) was cloned in the pET30
vector between the restriction sites NdeI and XhoI for ex-
pression as a tag-less protein.
After transformation of these vectors into E. coliRosetta
(DE3)pLysS, cells were grown at 37◦C in Luria Broth me-
dia, supplemented with 25 g/ml chloramphenicol and
50 g/ml kanamycin, until an optical density at 600
nm (OD600) of 0.8 and protein expression was induced
by adding 1mM isopropyl -D-1-thiogalactopyranoside
(IPTG). After overnight induction at 37◦C, cells were har-
vested by centrifugation and resuspended in buffer A (50
mM TRIS pH 8, 1 M NaCl, 1 mM DTT) supplemented
with 50 g/ml DNase I, 5 mM MgCl2, AEBSF (at 0.1
mg/ml) and leupeptin (at 1 g/ml). After cell disrup-
tion using a cell disruptor system (Constant Systems) and
clearance of the lysate via centrifugation, all Trm10 con-
structs containing a histidine-tag were purified by a two-
step purification protocol consisting of immobilized metal
affinity chromatography followed by size exclusion chro-
matography. The supernatant was applied to a Ni2+-NTA
sepharose column (GE Healthcare), and after extensive
washing with buffer A supplemented with 10 mM imida-
zole, the his-tagged proteins were eluted with buffer A con-
taining 150 mM imidazole. Fractions containing the pro-
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ther a Superdex200 (for full length SaTrm10) or Superdex75
(for SaTrm10 1–249) size exclusion chromatography col-
umn (GEHealthcare). The running buffer in this step for
full length SaTrm10 protein was 20 mM TRIS pH 8, 100
mM NaCl, 50 mM imidazole and 1 mM DTT while for
the SaTrm10 1–249 construct 20 mM TRIS pH 8, 100 mM
NaCl, 1 mM DTT was used.
Selenomethionine enrichment of the SaTrm10 1–249 con-
struct was accomplished by feedback inhibition of the me-
thionine biosynthesis pathway. Here, minimal media was
prepared according to the protocol described in Marley
et al. (20) but supplemented with 0.5% glucose and 0.001%
thiamine. The cultures were allowed to grow at 37◦C un-
til an OD600 of 0.7 was reached. At this point the amino
acids lysine, phenylalanine, threonine (at a final concentra-
tion of 100 mg/l), isoleucine, leucine, valine (at a concentra-
tion of 50 mg/l) and selenomethionine (at a concentration
of 60 mg/l) were added. Thirty minutes after addition of
these amino acids, over-expression was started by addition
of 1 mM IPTG. Expression of selenomethionine enriched
protein was continued for 20 h at 37◦C prior to harvesting
the cells. Hereafter, the selenomethionine enriched proteins
were treated and purified similar to the native protein.
The SaTrm10 construct lacking a histidine-tagwas recom-
binantly expressed in a similar way. The purification proto-
col of this protein included an incubation step at 70◦C for
20 min, after which the denatured proteins were removed
by centrifugation for 45 min at 39000 rcf. This was followed
by an ion exchange chromatography step on a Source 30S
cation exchange column (GE Healthcare) run in 20 mM
MES pH 6, 50mMNaCl, 0.2 mM -mercaptoethanol. Elu-
tion of the SaTrm10 protein from the column was accom-
plished by increasing NaCl concentration. The final purifi-
cation step consisted of a size exclusion chromatography
step identical to the one in the purification protocol of the
histidine-tagged protein. The purity of the obtained sample,
as determined by SDS-PAGE, was of similar quality as the
purified histidine-tagged protein samples, although yields
were lower. The histidine-tagged protein was used for all the
experiments described in this manuscript, except when ex-
plicitly stated otherwise.
Multi-angle light scattering (MALS) and small-angle X-ray
scattering (SAXS) analysis
Multi-angle light scatter experiments coupled to size exclu-
sion chromatography (SEC-MALS) were performed with a
Dawn Heleos (Wyatt technology) detector (using 9 angles)
connected to an Agilent Bio-SEC 3 (size exclusion chro-
matography) column attached to an HPLC system (Wa-
ters). Twenty microlitres of a SaTrm10 protein solution at 10
mg/ml (either with or without histidine-tag) was injected on
the column, which was eluted at a flow rate of 0.2 ml/min
in 20 mM TRIS pH 8, 100 mM NaCl, 50 mM imidazole,
1 mM -mercaptoethanol. The molar mass was calculated
with the ASTRA 5.3.4.20 software.
All SAXSmeasurements were performed on the SWING
beamline (Soleil, France) with an in line size exclusion chro-
matography system attached before the SAXS set-up. Here,
50 l of protein at 10 mg/ml was injected on an Agilent
Bio-SEC 3 column (300 A˚ pore size), which was eluted
at 0.2 ml/min in a 20 mM Tris pH 8, 1 M NaCl, 1 mM
DTT buffer. Eighteen SAXS frames, each exposed for 1.5 s,
were collected at the size exclusion chromatography elution
peak. The separate SAXS curves were qualitatively evalu-
ated, scaled and averaged using the ATSAS software pack-
age (21). The oligomerisation state of the SaTrm10 protein
was determined using the SAXSMoW application over a q-
range of 0.01 A˚−1 < q < 0.4 A˚−1 (22). Fitting of the experi-
mental SAXS curve (between a q-range of 0.01 A˚−1 and 0.5
A˚−1) with the theoretically calculated SAXS curve of the B-
chain of the SaTrm10 SAH crystal structure was performed
by CRYSOL and included a constant subtraction to remove
systematic errors (23).
Crystallisation and data collection of SaTrm10 constructs
Crystals of selenomethionine enriched SaTrm10 1–249 were
obtained by mixing protein (at a concentration of 15
mg/ml) with an equal volume of crystallisation buffer in
a hanging drop vapour diffusion set-up. The crystallisa-
tion solution contained 8% ethylene glycol, 0.1 M HEPES
pH 7.5, 10% PEG8k. Crystals were flash frozen with 25%
glycerol as cryoprotectant. Diffraction data of these crys-
tals were collected at 100 K at beamline Proxima I of
Soleil (France). The Se-SAD data set of SaTrm10 1–249
(SaTrm10 1–249 SAD) was collected at the selenium ab-
sorption peak (0.979 A˚) as determined by a fluorescence
scan.
Subsequently crystals of selenomethionine enriched
SaTrm10 1–249 were obtained using 2% dioxane, 0.05 M
Bicine pH 9 and 15% PEG20k as crystallisation condition.
Crystals were flash frozen in liquid nitrogen with crystalli-
sation buffer containing 35% PEG200 as cryoprotectant.
Diffraction data were collected at 100 K at beamline Prox-
ima I of Soleil (France).
Crystals of full length SaTrm10 were obtained by mixing
protein (at a concentration of 8 mg/ml) in the presence of
1 mM SAH with an equal volume of crystallisation buffer
in a hanging drop vapour diffusion set-up. The crystallisa-
tion solution contained 0.4 M (NH4)2SO4, 0.1 M sodium
acetate pH 4.5 and 15–20% PEG2000MME. Plate like crys-
tals appeared several months after setting up the crystallisa-
tion plates at 20◦C. Crystals were cryoprotected in the crys-
tallisation condition supplementedwith 15%PEG200 and 1
mM SAH and flash frozen in liquid nitrogen prior to data-
collection at 100 K at beamline I24 of the Diamond light
source (UK).
X-ray crystallography data processing, refinement and struc-
ture analysis
Data indexing, integration and scaling were done using
the XDS suite (24). As criterion for high resolution cut-
off an I/(I) > 1.5 and CC1/2 value > 50% was used. The
selenomethionine substructure of the SaTrm10 1–249 SAD
data set was calculated using SHELX C/D (25) in the
HKL2MAP graphical user interface. Subsequent phasing,
substructure refinement and density modification was per-
formed in the autoSHARP pipeline (26) in ccp4 (27). An
atomic model was built within the autoSHARP pipeline us-
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was later used as search model in the molecular replace-
ment using Phaser for the SaTrm10 SAH and SaTrm10 1–
249 data sets (29). Automated model building for the
SaTrm10 SAH data set was performed by BUCCANEER
(30), while ARP/wARP was used for the SaTrm10 1–249
data set (28). Cycles between manual model building using
Coot (31) and automated refinement usingRefmac5 (32) led
to the final molecular models, in which the temperature fac-
tors were isotropically refined. The final models were vali-
dated with the MolProbity server (33). All data collection,
processing and validation statistics are summarized in Sup-
plementary Table S1.
Sequence alignments were performed with the T-coffee
server (34) while structural alignments were done using
PDBeFOLD and PyMOL (35). The Trm10 secondary
structure was assigned by DSSP (36) and the topology map
was created by PDBsum (37). The presented SAHomitmap
shows a Fo-Fc map contoured at 2 sigma created through
the FTT program (38) in the CCP4 software package and
visualised in pymol. Poisson-Boltzmann electrostatics were
calculated with the PARSE force field in PDB2PQR (39)
and visualised with APBS (40) in PyMOL. All figures were
created in Pymol (www.pymol.org).
Isothermal titration calorimetry (ITC)
Prior to the ITC experiments, WT SaTrm10 and all the
protein variants were dialysed extensively against a buffer
consisting of 20 mM Tris pH 8, 100 mM NaCl, 50 mM
imidazole and 1 mM -mercaptoethanol. S-adenosyl me-
thionine (SAM) was dissolved in this dialysis buffer and
the concentration was determined using the absorbance
at 260 nm (260 nm = 15400 M−1cm−1). ITC experiments
were performed with a MicroCal ITC200 Instrument (GE
Healthcare, Northampton, MA, USA) using a reference
power of 10 microcal/sec. SAM (2 mM stock concentra-
tion) was titrated in the cell containing 150 M SaTrm10
WT, SaTrm10 D220N, SaTrm10 D184N or SaTrm10 G180P
protein in a 20 mM Tris pH 8, 100 mM NaCl, 50 mM im-
idazole and 1 mM -mercaptoethanol buffer at 25◦C. For
each experiment a preliminary 0.4l injection (not included
in data analysis) was followed by 20 injections of each 2 l
with a duration of 4 s at a stirring speed of 400 rpm and
intervals of 180 s. The initial delay was 120 s. Data were
fitted using MicroCal Origin version 7.0 (GE Healthcare,
Northampton, MA, USA). To determine the heat of dilu-
tion, 2 mM SAM was titrated against buffer and a buffer
solution was titrated against 150 M SaTrm10.
In silico tRNA-SaTrm10 docking
Since the molecular structure of tRNAMet from Sulfolobus
acidocaldarius is not available, we have built its homology
model with ModeRNA (41) using the crystal structure of
E. coli initiator tRNA (PDB: 3cw5) as a template. The
model was refined using the QRNAS optimization tool (J.
Stasiewicz and J.M. Bujnicki, unpublished). RNA-binding
residues on the SaTrm10 surface were predicted using the
PPRINT web server (42) and by identifying regions of pos-
itive electrostatic potential.
In order to model the structure of the complex be-
tween SaTrm10 SAH and tRNAMet, we used a computa-
tional docking approach. A set of 100 alternative models
was produced using the hybrid modelling method PyRy3D
(in house method available: http://genesilico.pl/pyry3d/) by
docking either of the components (tRNA or Trm10) to the
other. PyRy3D was configured to minimize violation of the
following distance restraints: (i) between the SAM ligand
(methyl group donor) and nucleotide 9 of tRNAMet (methyl
group acceptor) and (ii) between the protein residue Lys64
(predicted to be involved in RNA binding) and any atom
of tRNAMet. Obtained models were clustered according to
their mutual similarity with the threshold of 5 A˚. As a result
we received three clusters consisting of 27, 11 and 8 models,
respectively. Representatives (best scored models according
to PyRy3D scoring function) of these clusters were selected
for further analysis, in particular for experimental valida-
tion.
Using additional data from EMSA and activity measure-
ments of Trm10 variants, we filtered models from the three
obtained clusters. In particular, we applied FILTREST3D
(43) to find a model that fulfils all distance restraints in-
ferred from experimental analyses. This filtering procedure
revealed that a highly-scored model from the second clus-
ter (containing 11 models) agreed best with the entire set of
experimental data. Therefore, we selected this model as the
most probable representation of the structure of the com-
plex. Finally, we optimized local protein-RNA contacts and
the binding interface in the selectedmodel by performing an
optimisation procedure implemented in the NPDock tool
(44). The final model of the complex is available via a pub-
lically accessible ftp server at: ftp://ftp.genesilico.pl/iamb/
models/trm10.
Preparation of tRNA and in vitro tRNA binding and methyl-
transferase assays
The two tRNA methyltransferase assays used in this work
are described by Droogmans et al. (45). Briefly, the first
method consisted in measuring the amount of 14C trans-
ferred to total E. coli tRNA using [methyl-14C]SAM as
methyl donor. The reaction mixture (400 l) consisted of
50 mM Tris pH 8, 5 mM MgCl2, 60 g unfractionated E.
coli tRNA, 25 nCi [methyl-14C]SAM (50 mCi/mmol; GE
Healthcare) and enzyme (5 to 10g). After an incubation of
30 min at 60◦C the reaction was stopped by phenol extrac-
tion and the tRNAs were TCA (trichloroacetic acid) pre-
cipitated. Radioactive tRNA was captured on a filter and
washed three times with ethanol prior to the measurement
of the radioactivity in a scintillation counter.
The second type of tRNA methyltransferase assay in-
volved in vitro transcribed 32P-labelled tRNAiMet of S.
acidocaldarius (11). Radioactive (32P) in vitro transcripts
were obtained according to Reyes and Abelson, 1987 (46)
using [32P]ATP. The reaction mixture for the tRNA-
methyltransferase assay (400 l) consisted of 50 mM Tris-
HCl pH 8, 5 mM MgCl2, 106 cpm of the radioactive tran-
script, 500 MSAM and 0.05–5 g of purified enzyme. Af-
ter 30 min of incubation at 60◦C the reaction was stopped
by phenol extraction and the tRNA was ethanol precipi-
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digested by nuclease P1 (1 g) in the presence of 5 g to-
tal yeast tRNA as carrier. Modified nucleotides were anal-
ysed by 2D thin layer chromatography (TLC) on cellulose
plates. Radioactive nucleotides corresponding to 5′ pA and
5′ pm1A (reference map of nucleotide migration described
in Grosjean et al. (47)) were visualized by autoradiography
and quantified by densitometry.
For the electrophoretic mobility shift assay (EMSA),
2.104 cpm of radioactive [32P]ATP transcript from
tRNAiMet of S. acidocaldarius was incubated in the pres-
ence of 1 g enzyme in 50 mM Tris pH 8, 5 mM MgCl2 at
60◦C. The binding reaction (with a total volume of 20 l)
was stopped by the addition of 4 l of stop solution (0.05%
bromophenol blue ogin 30% glycerol) and the mixture was
separated by polyacrylamide gel electrophoresis (on a 6%
PAGE gel with dimensions 190 mm x 160 mm x 1.5 mm)
in TB buffer at room temperature. The electrophoresis was
performed at a voltage of 180 V until the samples entered
the gel and further at 150 V until the end of the run (1 12 h).
RESULTS
Both eukaryal and archaeal Trm10 proteins exist as
monomers in solution
Until recently, it was believed that all SPOUT proteins
function as dimers (16). However, in 2013 Shao et al. ex-
perimentally showed that yeast Trm10 is monomeric in
solution (14). The uncommon monomeric nature of the
yeast Trm10 proteins within the dimeric SPOUT family
raises questions on the oligomerisation state of the archaeal
Trm10 homologues. In order to experimentally determine
the oligomerisation state of an archaeal Trm10 protein, we
performed multi-angle light scatter (MALS) and small an-
gle X-ray scatter (SAXS) experiments on purified Trm10
of Sulfolobus acidocaldarius (SaTrm10). Our multi-angle
light scatter experiments were performed on a 10 mg/ml
SaTrm10 protein solution which was run on a size exclusion
chromatography column prior to the MALS measurement
(SEC-MALS). In order to exclude any influence of the pu-
rification tag on the oligomerisation state, the SEC-MALS
experiments were performed both on SaTrm10 containing
anN-terminal histidine-tag and on the tag-less variant. This
analysis yielded a molecular mass for the protein in solu-
tion of about 38 kDa for the histidine-tagged protein and
35 kDa for the tag-less protein (Figure 1A), values which
corresponds best with the theoretical molecular mass of a
SaTrm10 monomer (33.2 kDa for tag-less protein, 35.3 kDa
for protein with histidine-tag). This monomeric nature of
the SaTrm10 protein in solution was further confirmed by
SAXS experiments, in which a 10 mg/ml SaTrm10 solution
(with histidine-tag) was run on a size exclusion chromatog-
raphy column in-line with SAXS data collection. The pro-
tein eluted as a single peak from the column and analysis
of the scaled and merged scatter curves with the SAXS-
MoW software yielded an experimental molecular mass of
31.8 kDa, thus confirming the monomeric arrangement of
the SaTrm10 protein in solution (Figure 1B). Hence, un-
like other SPOUT proteins, both the eukaryal and archaeal
Trm10 proteins exist (and likely function) as monomers in
solution.
Crystallisation and structure determination of SaTrm10
In order to gain insight in the tRNA binding mechanism
and the molecular origin for substrate specificity of Trm10
proteins, we set out to solve the crystal structure of the
adenosine specific SaTrm10 protein. In first instance a crys-
tal structure of a truncated construct of SaTrm10, lacking
the C-terminal domain and enriched in selenomethionine,
was solved using SAD phasing at a resolution of 2.4 A˚ (this
structure will be referred upon as SaTrm10 1–249 SAD).
This structure was subsequently used to solve the struc-
ture of the same protein construct to a resolution of 2.1 A˚
using molecular replacement (SaTrm10 1–249). Given that
the SaTrm10 1–249 SAD and SaTrm10 1–249 crystal struc-
tures are virtually identical and that the latter has a higher
resolution, the SaTrm10 1–249 structure will be used for fur-
ther analysis in the remainder of this manuscript. Crystals
derived from full length SaTrm10 were obtained in an unre-
lated crystallisation condition and its crystal structure was
determined at 2.5 A˚ resolution through molecular replace-
ment using the SaTrm10 1–249 SAD structure as search
model. In the crystal structure of full length SaTrm10 the
reaction product S-adenosyl homocysteine (SAH) is bound
in the SAM binding pocket and therefore this structure will
be referred to as SaTrm10 SAH in the remainder of the text.
The data-collection, processing and refinement statistics for
all crystal structures are summarized in Supplementary Ta-
ble S1.
The SaTrm10 1–249 (and SaTrm10 1–249 SAD) crys-
tal structure contains one protein chain in the asymmet-
ric unit and shows clear electron density for the com-
plete polypeptide except for the three C-terminal amino
acids. In contrast, the full length SaTrm10 crystal structure
(SaTrm10 SAH) has two molecules in the asymmetric unit
and in both molecules one region of the protein, residues
182–202 in theA-chain and residues 182–194 in theB-chain,
could not be modelled due to missing electron density.
While the SaTrm10 SAH crystal structure has SAH bound
in both active sites of the asymmetric unit, the SaTrm10 1–
249 crystal structure did not contain a bound ligand in the
active site. The SAH found in the SaTrm10 SAH crystal
structure was included (at a concentration of 1 mM) in the
initial crystallisation condition. It should be noted that the
electron density corresponding to the homocysteine moiety
of SAH is better defined in the B-chain than in the A-chain.
SaTrm10 consists of a central SPOUT domain linked to an
N-terminal domain and a C-terminal helical domain
The crystal structure of monomeric, full length
SaTrm10 SAH displays an overall (tRNA resembling)
L-shape and can be divided in three regions: a central
domain (residues 89–246) which adopts a typical SPOUT
fold, an N-terminal domain (residues 1–79) and a C-
terminal helical domain (residues 247–292) (Figure 2A
and Supplementary Figure S2). The N-terminal domain
is formed by a curved -sheet and two -helices which
together resemble a horse shoe. Two long, curved anti-
parallel -strands (2 and 3) form the tip of the horse
shoe, while the heel is formed by two -helices (1 and
2) which are linked to each other by a central -strand
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Figure 1. (A) SEC-MALS analysis of SaTrm10 indicates that the protein is monomeric in solution (theoretical molecular mass of a monomer of SaTrm10
is 33.2 kDa for the tag-less protein and 35.3 kDa for the histidine-tagged variant). Light scatter (on the left axis) is shown as a function of the elution time
for the histidine-tagged SaTrm10 (red) and tag-less SaTrm10 (blue). The experimentally calculated molecular mass of the main peak (on the right axis) is
shown in green and purple, respectively. (B) Overlay of the experimental SAXS curve (blue) of SaTrm10 (histidine-tagged) with the theoretical SAXS curve
calculated from the SaTrm10 SAH crystal structure (red). The residual of the fit is shown below.
to be unique among the known protein structures, since a
search using the DALI server did not reveal the presence
of a similar conformation in the PDB database (48). The
N-terminal domain is connected by a long, flexible linker
to the SPOUT domain. Both domains also interact with
each other through H-bonds (connecting the backbone
of Thr2 with the backbone of Glu234 and the side chain
of Gln29 with the backbones of Arg120 and Leu123) and
hydrophobic interactions (residues Leu3, Leu36, Leu84
and Trp124). The central SPOUT domain adopts the
classical SPOUT fold, consisting of 7 parallel -strands
and 5 -helices, and is linked to the C-terminal domain of
SaTrm10 SAH through its most C-terminal -helix (7).
The two longest -helices of the SPOUT domain (3 and
6) are orientated parallel to each other on one side of
the central -sheet. These helices form the dimerisation
surface in classical SPOUT dimers. However, this type of
dimerisation is sterically prohibited in monomeric SaTrm10
by the presence of helix 7, which interacts with helix 6,
and by the C-terminal domain (Figure 2). Compared to
the founding members of the SPOUT family, TrmD and
TrmH, SaTrm10 possesses a significantly enlarged helix 3,
while helix 6 is shortened (49,50). Finally, the C-terminal
domain is composed of three -helices, from which residues
Arg255 and Gln247 of the first helix (8) interact through
H-bonds with loop 10-6 of the SPOUT domain.
Globally, the SaTrm10 crystal structures (SaTrm10 SAH
and SaTrm10 1–249) superimpose well on each other (Sup-
plementary Figure S3). The individual N-terminal and
SPOUT domains of both SaTrm10 structures superimpose
nearly perfect with root mean square deviations (rmsd) be-
tween C atoms of 0.7 A˚ and 0.6 A˚, respectively. How-
ever, the relative orientation of the N-terminal domain
with respect to the SPOUT domain slightly differs in the
SaTrm10 SAH and the SaTrm10 1–249 structure (Supple-
mentary Figure S3A). This observation indicates that there
is a certain degree of flexibility between the domains.
Despite this flexibility, SAXS analysis of the full length
SaTrm10 protein shows a very good fit (chi-value of 1.49
for q-values between 0.01 A˚−1 and 0.5 A˚−1) between the
experimentally determined SAXS curve of SaTrm10 and a
theoretically calculated SAXS curve from the B-chain of
the SaTrm10 SAH crystal structure using the CRYSOL pro-
gram (Figure 1B)) (23).
Some structural differences between the SaTrm10 SAH
and SaTrm10 1–249 crystal structures are also observed
within the SPOUT domains. The first difference concerns
a small shift in the orientation of the N-terminus of helix
3, which likely also represents flexibility in the SaTrm10
structure (Supplementary Figure S3A). A second, more im-
portant, difference concerns the region preceding helix 5
(Supplementary Figure S3B). While this region (residues
182–194) could not be modelled in the SaTrm10 SAH crys-
tal structure, it is clearly visible in the SaTrm10 1–249
crystal structure and forms a small anti-parallel -sheet
(containing strands 9 and 9′). However, superposition
on SaTrm10 SAH shows that this region would block the
SAM/SAH binding site. In particular the side chains of
Ile182 and Arg188 of the SaTrm10 1–249 structure would
occupy the same space as the ribose and homocysteine
moiety of SAH in SaTrm10 SAH. At present it is unclear
whether this conformation is mechanistically relevant (e.g.
in facilitating the release of the SAH reaction product) or is
an artefact of crystal packing.
The binding mode of the reaction product SAH to
SaTrm10, as seen in the SaTrm10 SAH structure, is similar
to the SAH binding of other SPOUT family members. Not
only is the SAM/SAH binding pocket of SaTrm10 SAH
located near the topological knot which characterises this
family, also the ‘bended conformation’ of SAH (charac-
terised by a O4′-C4′-C5′-S dihedral angle of 84◦) is main-
tained (Figure 2C) (51). The adenosine ring of SAHbinds in
a hydrophobic pocket formed by residues Leu158, Pro160,
Ile179, Ile209, and Ile225 (Supplementary Figure S4). Ad-
ditionally, H-bonds are formed between the backbone car-
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Figure 2. Crystal structure of SaTrm10 SAH (A) and SaTrm10 1–249 (B), shown in the same orientation (the B molecule of the SaTrm10 SAH crystal
structure is shown). In both panels, the domains of SaTrm10 are colour coded as followed: the N-terminal domain in blue, the SPOUT domain in green
and the C-terminal domain in pink. In panel A residues 182–194, which are missing in the SaTrm10 SAH model, are indicated by a green dotted line and
the reaction product SAH is shown as purple sticks. (C) An Fo-Fc omit map contoured at 2 of SAH in the SaTrm10 SAH structure. (D) Electrostatic
potential mapped on the solvent accessible surface of SaTrm10 SAH.Residues which are part of the positively charged surface are indicated. (E)A topology
map of SaTrm10 SAH.
adenine ring of SAH, and between the backbone of Gly180
(amide) and Leu158 (carbonyl) and the ribose moiety of
SAH.
tRNA is bound via interactions with all three domains of
SaTrm10
Mapping of the electrostatic potential on the solvent acces-
sible surface of SaTrm10 SAH shows a large surface patch
of positively charged residues spanning the N-terminal do-
main, the interface between the N-terminal domain and the
SPOUT domain and finally continuing into the C-terminal
domain (Figure 2D). It should also be noted that the un-
modelled region 184–192 of SaTrm10-SAH contains three
arginine and one lysine residues, which might become or-
dered and interact with the tRNA upon binding.
To obtain a more detailed image of the binding mode
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adopted a computational docking strategy as explained in
detail in the Materials and Methods section. To this end, a
homology model of the substrate, S. acidocaldarius initia-
tor tRNAMet (tRNAiMet) was built using ModeRNA (41),
using the crystal structure of E. coli initiator tRNA (PDB:
3cw5) as a template. As a result of the docking procedure
(in which the region around the target nucleotide A9 was al-
lowed to flip out from the core of the tRNAmolecule to al-
low entry into the active site pocket of SaTrm10-SAH), three
clusters of docking solutions were obtained (called cluster
1–3), of which the best-scored representatives are shown in
Supplementary Figure S5 (called models 1–3, respectively).
In model 1 and 2, the tRNAs are bound to SaTrm10-SAH
in an approximately similar fashion, although they are ro-
tated vis-a`-vis each other. Especially in model 2 the L-shape
of the tRNA coincides with the L-shape of the protein. In
contrast, in model 3 the bound tRNA is rotated about 180◦
compared to the models 1 and 2.
To further discriminate between our docking models, a
number of positively charged residues in the proposed inter-
action surfaces were substituted by glutamate residues (see
Supplementary Figure S6 for an SDS-PAGE of the puri-
fied protein variants), and the ability of the resulting protein
variants to bind tRNA substrate was determined by elec-
trophoretic mobility shift assays (EMSA) at a single protein
concentration (Figure 3G). In order to quantify the effect
of the amino acid residue substitutions on tRNA binding
the amount of unbound tRNA was measured on gel with
densitometry and normalized against the value for the wild-
type protein (set as 100% binding, Figure 3F). Addition-
ally the ability of these variants to methylate tRNA was de-
termined and compared to wild-type SaTrm10 (Figure 3E).
Considering the well established influence of Mg2+ ions on
the correct folding of tRNAand the corresponding effect on
modification reactions in the tRNA core (52,53), MgCl2 at
a concentration of 5 mM, which is optimal for activity, was
added to all assay buffers involving tRNA substrates (i.e.
EMSA and tRNAmethyltransferase measurements). Three
categories of (positively charged) residues were selected for
mutagenesis: (i) residues in the ‘tip’ of the N-terminal do-
main that would interact mainly with tRNA in model 2 and
to a lesser extend in model 1 and 3 (K38E, R47E, K64E,
R74E and K75E); (ii) residues in the SPOUT domain, with
one residue in the long -helix 3 (K121E) and one residue
in the flexible loop 184–192 (K185E); (iii) residues in the
C-terminal domain (K249E, R276E and R288E). In addi-
tion to the amino acid residue substitutions on the proposed
interface, two variants were included as negative controls
that affect residues outside of the proposed binding inter-
face (K5E and K78E).
Neither of the two protein variants that were included as
negative controls (K5E and K78E) significantly affect ac-
tivity, while, surprisingly, an effect of the K5E variant on
tRNAbinding is observed. Supplementary Figure S5 shows
the results of these mutagenesis datamapped on the accessi-
ble surface area in the context of models 1–3. This analysis
clearly validates the involvement of the positively charged
surface patch of SaTrm10 in tRNA binding. Moreover, the
large effects on tRNA binding and methyltransferase activ-
ity observed for themutations affecting residues in the tip of
theN-terminal domain (especially true forR47E,R74E and
K75E) strongly favour model 2 over model 1 and 3 (Figure
3C and D, and Supplementary Figure S5).
In the preferred docking model 2 the N-terminal do-
main of SaTrm10 SAH interacts with the anti-codon stem
and loop of the tRNA substrate, while the SPOUT domain
makes interactions with the variable loop, the T stem and
the region around nucleotide A9. The C-terminal domain
forms interactions with the acceptor stem and the part of
the D-stem that is flipped out to accommodate A9 into the
active site pocket (nucleotide 10–12) (Figure 3, panels A and
B). Accordingly, two out of three amino acid residue substi-
tutions in the C-terminal domain (K249E andR288A) have
large effects on binding and even more pronounced on ac-
tivity. This large effect on activity agrees with a role of this
domain in the flip-out mechanism. Finally, the loop region
184–192, harbouring the catalytic Asp184 residue (see fur-
ther) would be positioned ideally to close over the active site
upon tRNA binding. In agreement with such an induced fit
mechanism, a substitution of a positively charged residues
in this loop (K185E) affects catalysismore than tRNAbind-
ing (Figure 3).
N1-adenosine methylation by SaTrm10 requires two catalytic
aspartate residues
Based on the crystal structures of the SPOUT domain of
the guanosine specific yeast Trm10 proteins and on muta-
genesis data, Shao et al. suggested that an aspartate residue
(Asp207 in SpTrm10 and Asp210 in ScTrm10) might func-
tion as a catalytic base, which is needed to deprotonate
the N1 of the target guanosine during the methyl transfer
reaction (14). Deprotonation of this nitrogen will signifi-
cantly increase its nucleophilicity hence facilitating a nu-
cleophilic attack on the methyl group of SAM. Although
adenosine is not protonated at N1 at physiological pH, the
proposed catalytic aspartate residue is strictly conserved in
all eukaryal and archaeal Trm10 homologues and corre-
sponds to Asp184 in the A9-specific SaTrm10 and Asp206
in A9/G9-specific TkTrm10 (Supplementary Figure S2). In
the SaTrm10 SAH structure Asp184 is located on the un-
modelled flexible loop (residues 184–192) in the vicinity of
the SAM binding pocket.
Close examination of the SaTrm10 SAH crystal structure
revealed the presence of another aspartate residue (Asp220)
pointing into the active site and located close to the sulphur
atom of the bound SAH (Figure 4A). Interestingly, this as-
partate residue is conserved in the other archaeal (A9/G9
specific) Trm10 protein from T. kodakarensis (Asp245), but
not in the eukaryal guanosine-specific Trm10 homologues
(Supplementary Figure S2). To evaluate the importance
of both aspartate residues in the tRNA methyltransferase
mechanism of SaTrm10, we mutated them to asparagine
residues (D184N and D220N). These conservative sub-
stitutions would preserve the hydrogen-bonding capabili-
ties while disrupting any charge-charge interactions or pro-
ton transfer reactions at these positions. Subsequently, the
methyltransferase activity of both protein variants wasmea-
sured at different enzyme concentrations and compared to
the corresponding wild-type SaTrm10 activity (Figure 4B).
This analysis revealed that the activity of both variants is
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Figure 3. Docking model of tRNAiMet of S. acidocaldarius onto SaTrm10 SAH (model 2). For S. acidocaldarius tRNAiMet a homology model based on the
structure of E. coli tRNAiMet was used. (A) Docking model 2 with both tRNAiMet and SaTrm10 SAH shown in cartoon representation. The N-terminal,
SPOUT and C-terminal domains of SaTrm10 are coloured blue, green and pink, respectively. (B) Docking model 2 in the same orientation as in (A) with
SaTrm10 SAH shown with the electrostatic potential mapped on its solvent accessible surface. (C and D)Results of the mutagenesis data, as evaluated with
a tRNAmethylation assay (C) and EMSAmeasurements (D), mapped on the surface of docking model 2 (an SDS-PAGE of these protein variants is shown
in Supplementary Figure S6). The residues that have been substituted to validate the docking model are coloured according to the results of the tRNA
methylation assay (C) or EMSA (D) using the following colour code: green: 50–100% activity/binding compared to WT; orange: 50–20% activity/binding
compared to WT; red: 20–0% activity/binding compared to WT. (E, F and G) Results of the tRNA methylation assay using [methyl-14C]SAM (E), and of
the single concentration EMSA (F and G) of protein variants that were generated in this study to validate the docking model. Panel F displays the fraction
of bound tRNA normalized against the wild type protein, as determined from the EMSA shown in panel G. Hereto, the density of the band corresponding
to unbound tRNA was measured and compared to the band in absence of protein (labelled ‘tRNA’). The value of the wild type protein was set as 100%.
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Figure 4. Role of Asp184 and Asp220 in the catalytic mechanism of SaTrm10. (A) Overlay of the crystal structures of SaTrm10 SAH (green), SaTrm10 1–
249 (blue) and SpTrm10 (grey) showing the position of the catalytic residues (Asp184/Asp220 in SaTrm10 and Asp207 in SpTrm10). The bound reaction
product SAH is shown as purple sticks. Note that residue Asp184 could not be modelled in the SaTrm10 SAH crystal structure. (B) Methyltransferase
activity assay (with in vitro transcribed 32P-labelled SatRNAiMet) comparing the catalytic activity of wild-type SaTrm10 with the one of the D184N and
D220N variants at different protein concentrations (and a fixed tRNA concentration). (C) Isothermal titration calorimetry (ITC) assay comparing the
binding of SAM to either wild-type SaTrm10 or the D184N or D220N variant. Extra control experiments to determine the heat of dilution and using a
protein variant affected directly in the SAM binding pocket can be found in Supplementary Figure S7. (D) Electrophoretic mobility shift assay (EMSA)
showing the binding of SatRNAiMet on the wild-type, D184N or D220N SaTrm10 variant.
to an important role of both residues. To test whether any
of the above substitutions has an effect on the binding of
the methyl donor SAM, the binding affinity for this sub-
strate was determined using isothermal titration calorime-
try (ITC) measurements (Figure 4C). Moreover, as an extra
control also the heat of dilution was measured by titrating
SAM into buffer or by titrating buffer into a SaTrm10 so-
lution (Supplementary Figure S7). As a positive control,
SAM binding to a protein variant, G180P, affecting an
amino acid residue directly interacting with SAM was also
measured (Supplementary Figures S4 and S7). Wild-type
SaTrm10 binds SAM with an equilibrium dissociation con-
stant (KD) of 33± 4 M. In some cases very mild precipita-
tion of the protein in themeasure cell was observed after the
experiment which might lead to the observed stoichiometry
slightly below 1. The equilibrium dissociation constant of
SaTrm10 for SAM is higher than the corresponding values
reported forS. cerevisiae andS. pombeTrm10 (7.63Mand
4.46 M, respectively), but is in the same range as found
for other SPOUT methyltransferases (14,54). The D184N
and D220N variants have binding affinities for SAM which
are comparable to the one of the wild-type protein (KD =
28 ± 5 M and KD = 47 ± 8 M, respectively), indicat-
ing that their observed effect on activity is not caused by
an impaired SAM binding. This contrasts with what has
been found in S. cerevisiae and S. pombe Trm10, where
mutation of the residue corresponding to D184 (D210 and
D207, respectively) abrogates SAM binding (14). Reassur-
ingly, no binding under the used conditions is observed for
the G180P variant, in agreement with the interaction of the
latter residue with both hydroxyl groups of the ribose moi-
ety of SAM. Next, the tRNA binding of both protein vari-
ants (D184N and D220N) was compared to the wild-type
protein using an EMSA at one single protein concentration
(using the same conditions as for the interface mutants de-
scribed above). This analysis shows that tRNA binding is
nearly unaltered by both protein variations (Figure 4D). To-
gether these data show that SaTrm10 needs two aspartate
residues to catalyse the methyl transfer reaction to the N1
atom of A9. Thus, although the reaction mechanism is an-
ticipated to be significantly different for the transfer of a
methyl group to a protonated N1 of guanosine compared
to an unprotonated N1 of adenosine, the crucial role of
Asp184 seems to be conserved in both G9- and A9-specific
methyltransferases. On the other hand SaTrm10 requires a
second aspartate residue for catalysis (Asp220). Since this
residue is present in both the archaeal Trm10 homologues
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absent in the guanosine specific eukaryal proteins, this hints
toward a specific role of this residue in the N1-methylation
of adenosine.
DISCUSSION
SPOUT enzymes form a single superfamily ofRNAmethyl-
transferases that are characterized by an unusual / fold
with a deep topological knot (15,16). This knot forms the
binding site for the SAM methyl donor, and, in the com-
mon case where the SPOUT methyltransferases functions
as dimers, the active site is located at the dimer interface. Be-
sides a few exceptions like TrmL and RlmH, most SPOUT
proteins have N- and/or C- terminal extensions fused to the
SPOUT domain, which are assumed to participate in sub-
strate (RNA) binding (16). Trm10 is a SPOUT superfamily
member, conserved in eukaryotes and archaea, which is in-
volved in the methylation of the N1 atom of purine nucle-
osides at position 9 of tRNA. Previously crystal structures
of the SPOUT domain of the m1G9-forming Trm10 pro-
teins from S. cerevisiae and S. pombe have been reported
(14). Surprisingly, it was shown that these proteins func-
tion as monomers in solution, unlike all other so far stud-
ied SPOUTmethyltransferases. In this paper we present the
first experimental structure of a full length Trm10 homo-
logue from the archaeon S. acidocaldarius (SaTrm10 SAH),
that catalyses the N1-methylation of adenosine residues at
position 9 of tRNA (m1A9). The crystal structure as well
as our biochemical data (SAXS and SEC-MALS) clearly
show that this protein also exists as a monomer in solution,
indicating that this is a general feature of both eukaryal
and archaeal Trm10 enzymes. The structure of full length
SaTrm10 shows that the protein adopts an overall L-shaped
form which seems to mimic the overall shape of a tRNA
molecule. This fold is constructed from three distinguish-
able domains, consisting next to the SPOUT domain of an
N-terminal domain with a unique fold and an -helical C-
terminal domain. Sequence analysis reveals that also the
ScTrm10, SpTrm10, humanTRMT10A and TkTrm10 homo-
logues have such N- and C-terminal extensions with regard
to the SPOUT domain, although the sequence conserva-
tion in these regions is low between eukaryal and archaeal
Trm10 proteins (Supplementary Figure S2). Therefore, it re-
mains to be determined whether the N- and C-terminal do-
mains of all Trm10 proteins are structurally identical to the
here described domains of SaTrm10.
So far, very little information has been available on the
RNA binding mode of SPOUT methyltransferases. Only
one crystal structure of a SPOUT methyltransferase/RNA
complex was previously reported: that of the rRNAmethyl-
transferase Nep1 in complex with a 14-base RNA fragment
(55). In addition, the crystal structure of a TrmD/tRNA
complex was released during the revision process of this
manuscript (56). In both these structures the RNA binds
in a cleft on the interface of the subunits of the dimer. A
similar RNA binding mode is clearly impossible for the
monomeric Trm10 proteins. The SPOUT domain of the
ScTrm10 and SpTrm10 homologues was shown to be able
to bind to substrate tRNA on its own, although the N-
terminal domain also significantly contributes to binding
(14). However, we find that in SaTrm10 amino acid substitu-
tions in both the N-terminal and C-terminal domain com-
pletely disrupt tRNA binding, indicating differences in the
binding mechanism between eukaryal and archaeal Trm10
homologues. This difference is also reflected in the elec-
trostatics of the SPOUT domain of SaTrm10 SAH, which
is mostly negatively charged, while the SPOUT domains
of the eukaryal Trm10 proteins contain a clear positively
charged surface (Supplementary Figure S8, panels C–F). In
this regard, a particular structural difference between the
SPOUT domains of archaeal and eukaryal Trm10 homo-
logues concerns the region between 5 and 6 (residues
133–142 in SaTrm10) (Supplementary Figure S8A and B).
In all eukaryal proteins an -helix is present in this region,
which is absent in the SaTrm10 structure. Two residues in
this -helix have been shown to be involved in tRNA bind-
ing in SpTrm10 (14). Interestingly, this -helix also seems to
be important for the correct in vivo functioning of ScTrm10
since a serine to proline variant in this helix influences the
translational termination efficiency in S. cerevisiae (57). The
exact molecular mechanism of how a mutation in this helix
of ScTrm10 is influencing the translational termination effi-
ciency is still unclear at the moment, but a possibility would
be that this mutation in ScTrm10 prevents the binding and
subsequent methylation of certain substrate tRNAs.
The availability of the full length structure of SaTrm10
allowed us to calculate plausible docking models, which
illustrate how tRNA can bind to a monomeric SPOUT
protein. Using this strategy, three alternative docking so-
lutions were obtained. Subsequent experimental analysis
clearly favoured model 2 over the other two models (Fig-
ure 3). This docking model shows how the L-shape of the
protein nearly perfectly complements the L-shape of the
tRNA molecule. Interestingly, the SPOUT domain forms
interactions with the tRNA using its helices 3 and 6. In
other SPOUT proteins, these helices form the dimerization
surface between protomers (16), indicating that the Trm10
proteins have retuned their dimerization surface to serve in
tRNA binding. Apart from the SPOUT domain, major in-
teractions are formed between the substrate tRNA and the
N-terminal and C-terminal domains, where the N-terminal
domain interacts with the anti-codon stem and loop while
the C-terminal domain forms interactions with the accep-
tor stem and the part of the D-stem that is flipped out to
accommodate A9 into the active site pocket. A flexible loop
that could not be modelled in the crystal structure (amino
acids 184–192) would be ideally positioned to close over the
active site upon tRNA binding. This loop harbours residue
Asp184, which our data shows to be indispensable for catal-
ysis of the m1A9 modification reaction.
A remarkable aspect of the Trm10 proteins is the differ-
ence in substrate specificity between different homologues
of this protein (10,11). While the SaTrm10 protein, inves-
tigated in this study, is specific for the N1-methylation of
adenosine residues at position 9 of tRNA, the yeast Trm10
and human TRMT10A and TRMT10B orthologues are
specific for the N1-methylation of guanosine.Moreover, the
human mitochondrial TRMT10C orthologue and the or-
thologue from the archaeon T. kodakarensis show a dual
adenosine/guanosine specificity (11,19). This latter promis-
cuity in substrate specificity is surprising, considering that
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protonation states under physiological conditions: whereas
theN1 atomof guanosine ismainly protonated (pKa≈ 9.2),
the N1 atom of adenosine is not (pKa ≈ 3.5) (58). There-
fore, the currently described reaction mechanisms for the
N1-methylation of adenosine or guanosine are fundamen-
tally different. The N1-methylation of guanosine in tRNA
has been most thoroughly studied in the structurally unre-
lated m1G37 methyltransferases Trm5 and TrmD (59,60).
Both these enzymes rely on a catalytic base (aspartate or
glutamate) to deprotonate the N1 atom of guanosine in or-
der to facilitate the nucleophilic attack of the N1 atom on
the methyl group of SAM. In contrast, N1-methylation of
adenosine does not require deprotonation of the N1 atom,
although the nucleophilicity of the N1 atom is expected to
be intrinsically low considering its low pKa. In this con-
text it has been observed that the m1A58 methyltransferase
TrmI from Thermus thermophilus also relies on a catalytic
aspartate residue (61). Here, two possible roles were sug-
gested for this aspartate: (i) It could minimise the Gibbs
free energy of the transition state by positioning the methyl
donor SAM and target adenosine in an optimal orientation
and distance for the N1-methylation reaction or (ii) it could
deprotonate the N6 atom of adenosine to generate the ex-
ocyclic imino tautomer. This would subsequently activate
the lone electron pair on the N1 atom of adenosine, which
would in the same elementary step perform a nucleophilic
attack on the methyl group of SAM (61).
A catalytically important aspartate residue has been iden-
tified in the yeast Trm10 proteins (Asp210 in ScTrm10
and Asp207 in SpTrm10) which is also conserved in the
guanosine-specific human TRMT10A (Asp210) (14). In ac-
cordance with the mechanism of other m1G methyltrans-
ferases, a role as catalytic base in the deprotonation of the
N1 atom of the target guanosine has been proposed. Re-
markably, this aspartate residue is also conserved in the
m1A-specific SaTrm10 (Asp184) and the m1A/m1G-specific
TkTrm10 (Asp206). Although the N1 position is a priori ex-
pected to be unprotonated in adenosine, we found that this
Asp184 residue is required for catalysis of the m1A forma-
tion in SaTrm10. Moreover, structural comparison and se-
quence alignments revealed the presence of a second aspar-
tate residue in enzymes able to catalyse the m1A formation
(Asp220 in SaTrm10 and Asp245 in TkTrm10), but absent
in m1G-specific methyltransferases. Our mutagenesis and
kinetic/binding analysis shows that also this residue is re-
quired for efficient catalysis of m1A formation in SaTrm10.
Currently, the exact role of the two aspartate residues re-
quired for activity of SaTrm10 is still unclear. Further de-
tailed kinetic analyses will be required to shed more light
on the reaction mechanism and on the molecular basis of
the observed differences in substrate specificity among dif-
ferent Trm10 orthologues.
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